Avantect® Ovarian Cancer Test

About Bcal Diagnostics

Australian biotech delivering AI‑enhanced blood tests for early breast, pancreatic, and ovarian cancer detection.

About ClearNote Health

ClearNote Health is a commercial-stage diagnostics company leveraging its unique epigenomics platform to detect high-mortality cancers early via a simple blood draw. The company's core technology measures 5-hydroxymethylcytosine (5hmC) modifications in cell-free DNA, providing a sensitive and specific signal of developing cancer. Key achievements include NYSDOH approval and CMS reimbursement for its Avantect tests, selection for the NCI's Vanguard study, and a strategic focus on pancreatic and ovarian cancers. The company is expanding its leadership and commercial footprint to drive clinical adoption.

Therapeutic Areas